Jacob Smith

4 May 2026

A new injectable version of the cancer drug Keytruda could significan… – Jacob Smith

A new injectable version of the cancer drug Keytruda could significantly reduce hospital time for thousands of UK patients. The immunotherapy, which helps the body fight cancer, currently requires lengthy infusions, but the new form promises faster treatment, improving patient convenience and easing pressure on healthcare services. #UK #Healthcare #CancerTreatment #Keytruda #MedicalInnovation #NHS #HealthNews